Niagen Bioscience (NAGE) traded up 0.41 % during a 24 hours period ending at 05:16 AM Central Europe on Wednesday 28th. One Niagen Bioscience stock can currently be bought for about USD 2.5 on popular exchanges. Current supply of Niagen Bioscience stocks is 79.1 mn. Niagen Bioscience has a current market capitalization of USD 190.7 mn and approximately USD 990.2 k worth of Niagen Bioscience was traded on exchanges in the last 24 hours. Since last month end, Niagen Bioscience has traded -18.12 % down. Simple moving average of last 200 days is at USD 4. The highest price of past 52 weeks was recorded at USD 7.95 on 11/05/2025. 52 weeks low was at USD 2.39 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Meridian (MRBK) traded flat 0 % and now trades at USD 18.72. Current market capitalisation for Meridian is USD 227.5 mn. Current price/earnings ratio for Meridian is 10.31.
Helix Acquisition (HLXC) traded down -0.1 % and now trades at USD 10.31. Helix Acquisition has a market capitalisation of USD 227.2 mn.
Global Water (GWRS) traded down -1.77 % and now trades at USD 7.83. Global Water has a market capitalisation of USD 228.1 mn. Current price/earnings ratio for Global Water is 71.87.
American Well (AMWL) traded down -0.22 % and now trades at USD 13.59. Current market capitalisation for American Well is USD 224.8 mn.
Palisade Bio (PALI) traded down -7.52 % and now trades at USD 1.2. Palisade Bio has a market capitalisation of USD 228.3 mn.
About Niagen Bioscience
ChromaDex Corporation is a health care company operating in the life sciences tools and services sector with its main base located in Los Angeles, United States. The company is actively involved in research related to nicotinamide adenine dinucleotide, a significant factor in healthy aging studies. ChromaDex provides services and resources for customers residing within the United States, governed by the Nasdaq stock exchange. The official website for the company is accessible under www.chromadex.com .